Close

Analyst Ratings for Emergent BioSolutions (EBS) [Sells]

EBS Rating Summary

EBS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on EBS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $10.25 (+202.4%) * Over Last 12-Mos
Rating Score: 5.6 / 10   Percentile Rank: 60%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/20/2023 JPMorgan Jessica Fye New Coverage Underweight
(N/A)
N/A
(N/A)
2.12
(3.39)
59.91% Details
Like EBS Ratings? Also take a look at AAP, KVUE, JNJ, SPGI

EBS Ratings News